QuickView for SA_PROGRAMMED_CELL_DEATH (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
2. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
3. L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
4. Gene Expression Profiles of Head and Neck Squamous Cell Carcinoma (HNSCC) primary tumors
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)

There were no matches for SA_PROGRAMMED_CELL_DEATH

1. Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy fo…
2. Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembro…
3. Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in A…
4. Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Local…
5. Regenerative Stem Cell Therapy for Stroke in Europe